Searchable abstracts of presentations at key conferences in endocrinology

ea0067o66 | Oral Presentations | EYES2019

Influence of empagliflozin on serum calcium and phosphorus concentrations in patients with type 2 diabetes

Lebedev D , Babenko A

Background and aims: Recent studies shows that SGLT-2 inhibitors affect phosphorus and calcium homeostasis in healthy individuals, but their effects in patients with type 2 diabetes are still unclear. The aim of this study was to evaluate effects of empagliflozin on parameters of calcium and phosphorus metabolism in patients with type 2 diabetes mellitus (T2DM) and preserved kidney function.Materials and methods: The subjects were 30 patients with T2DM, ...